# A Novel Iron-Based Supplement for Athletes Aged 18-25: Phase II

> **NCT06269913** · NA · ACTIVE_NOT_RECRUITING · sponsor: **University of Calgary** · enrollment: 30 (estimated)

## Conditions studied

- Iron Deficiencies

## Interventions

- **OTHER:** FeSC

## Key facts

- **NCT ID:** NCT06269913
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-06-17
- **Primary completion:** 2025-03-12
- **Final completion:** 2025-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-05-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06269913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06269913, "A Novel Iron-Based Supplement for Athletes Aged 18-25: Phase II". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06269913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*